BOT 5.48% 34.5¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-199

  1. 1,043 Posts.
    lightbulb Created with Sketch. 268
    I just hope now that we see a clear seperation in the derma study, like we have in the Australian arm.

    Frankly i think they are clutching at straws explaining the vehicle manufacturing process as the problem... I think they stuffed the trial but dont want to admit it as it may stop them proceeding to phase 3.

    What a big shame. Would have been a stellar result otherwise
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.5¢
Change
-0.020(5.48%)
Mkt cap ! $547.3M
Open High Low Value Volume
35.5¢ 35.5¢ 34.0¢ $4.566M 13.13M

Buyers (Bids)

No. Vol. Price($)
11 410003 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 346713 8
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.